机构:[1]Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China神经外科中国国际神经科学研究所介入放射科[2]International Neuroscience Institute (China-INI), Beijing, China[3]Division of Neuroradiology, Department of Medical Imaging, Toronto Western Hospital, Toronto, Canada[4]Department of Neurosurgery, Beijing Haidian Hospital, Beijing, China[5]Department of Neurosurgery, Beijing United Family Hospital, Beijing, China
The natural history of intradural spinal cord arteriovenous shunts is unknown. We performed an observational study in a consecutive patient cohort with symptomatic intradural spinal cord arteriovenous shunts who were admitted to three institutes to investigate the clinical course of this complex disease, which would provide valuable evidence to inform clinical decision-making. The clinical course of patients with symptomatic intradural spinal cord arteriovenous shunts from initial presentation to occurrence of clinical deterioration, initiation of treatment, or last follow-up was analysed. Patients with at least 1 month of observation were included in this study. Clinical onset and deterioration patterns were divided into acute and gradual. Annual and cumulative rates of clinical deterioration as well as their risk factors were analysed using Kaplan-Meier life table analysis and Cox proportional hazards model. To assess risks and benefits of treatment, post-treatment clinical courses were further assessed. Four hundred and sixty-six patients with a mean observational period of 36.9 ± 58.8 months were included; 56.7% of patients presented with acute onset, of whom 77.3% experienced spontaneous recovery. Age of onset older than 28 years, initial modified Aminoff and Logue scale of >3, mid-thoracic lesions and non-ventral lesions were independent predictors of failure for spontaneous recovery. The annual risk of general, acute and gradual clinical deterioration after onset was 30.7%, 9.9% and 17.7%, respectively. Risk of deterioration was highest in the early period after initial onset. Acute onset was the only independent risk factor [hazard ratio 1.957 (95% confidence interval, CI 1.324-2.894); P = 0.0008] of acute deterioration and gradual onset was the strongest predictor [hazard ratio 2.350 (95% CI 1.711-3.229); P < 0.0001] of the gradual deterioration among all the stratifying factors. After invasive treatment, complete obliteration was achieved in 37.9% of patients (138 of 364) and improved or stable clinical status was noted in 80.8% of patients. Forty-two patients (11.5%) experienced permanent complications. Overall post-treatment deterioration rate was 8.4%/year, and 5.3%/year if permanent complications were excluded. The natural history of symptomatic spinal cord arteriovenous shunts is poor, especially in the early period after onset, and early intervention is thus recommended. Initial onset pattern significantly affects the natural history of the lesion, which prompts a differentiated treatment strategy.
? The Author(s) (2019). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
第一作者机构:[1]Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China[2]International Neuroscience Institute (China-INI), Beijing, China
共同第一作者:
通讯作者:
通讯机构:[1]Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China[*1]Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, 45 Chang Chun St, Beijing, 100053, China[2]International Neuroscience Institute (China-INI), Beijing, China
推荐引用方式(GB/T 7714):
Jia-Xing Yu ,Tao Hong ,Timo Krings ,et al.Natural history of spinal cord arteriovenous shunts: an observational study.[J].BRAIN.2019,142:2265-2275.doi:10.1093/brain/awz153.
APA:
Jia-Xing Yu,,Tao Hong,,Timo Krings,,Chuan He,,Ming Ye,...&Hong-Qi Zhang.(2019).Natural history of spinal cord arteriovenous shunts: an observational study..BRAIN,142,
MLA:
Jia-Xing Yu,,et al."Natural history of spinal cord arteriovenous shunts: an observational study.".BRAIN 142.(2019):2265-2275